Literature DB >> 18014170

Epidemiological Studies on Relapsing Fever in California.

H L Wynns, M D Beck.   

Abstract

Entities:  

Year:  1935        PMID： 18014170      PMCID： PMC1559060          DOI： 10.2105/ajph.25.3.270

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  1 in total

1.  RELAPSING FEVER IN NORTH AMERICA, WITH REPORT OF AN OUTBREAK IN BRITISH COLUMBIA.

Authors:  J H Palmer; D J Crawford
Journal:  Can Med Assoc J       Date:  1933-06       Impact factor: 8.262
  1 in total
  5 in total

1.  A novel surface antigen of relapsing fever spirochetes can discriminate between relapsing fever and Lyme borreliosis.

Authors:  Job E Lopez; Merry E Schrumpf; Vijayaraj Nagarajan; Sandra J Raffel; Brandi N McCoy; Tom G Schwan
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

2.  First isolation of the relapsing fever spirochete, Borrelia hermsii, from a domestic dog.

Authors:  Ashley L Kelly; Sandra J Raffel; Robert J Fischer; Michael Bellinghausen; Connie Stevenson; Tom G Schwan
Journal:  Ticks Tick Borne Dis       Date:  2013-11-16       Impact factor: 3.744

3.  Host associations and genomic diversity of Borrelia hermsii in an endemic focus of tick-borne relapsing fever in western North America.

Authors:  Tammi L Johnson; Robert J Fischer; Sandra J Raffel; Tom G Schwan
Journal:  Parasit Vectors       Date:  2016-11-10       Impact factor: 3.876

4.  Ecological niche modeling and distribution of Ornithodoros hermsi associated with tick-borne relapsing fever in western North America.

Authors:  Kylie M Sage; Tammi L Johnson; Michael B Teglas; Nathan C Nieto; Tom G Schwan
Journal:  PLoS Negl Trop Dis       Date:  2017-10-30

5.  Tick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, USA.

Authors:  Tom G Schwan; Sandra J Raffel; Merry E Schrumpf; Merry E Schrumpf; Larry S Webster; Adriana R Marques; Robyn Spano; Michael Rood; Joe Burns; Renjie Hu
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.